2. Academic Validation
  3. Curcumin Inhibits Lipopolysaccharide-Induced Inflammation Through the HMGB1/NF-κB Signaling Pathway to Promote the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells

Curcumin Inhibits Lipopolysaccharide-Induced Inflammation Through the HMGB1/NF-κB Signaling Pathway to Promote the Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells

  • Mol Biotechnol. 2025 May 1. doi: 10.1007/s12033-025-01437-1.
Jimei Zhang # 1,  Donggang Mou # 2,  Ling Zhu 3,  Jianping Zhou 3,  Qunying Yu 4,  Guangyuan Yang 5,  Chaoli Luo 6,  Jianguo Meng 7,  Kewang Mao 8,  Jing Liu 3,  Bo Yan 9,  Xuming Yang 10
Affiliations

Affiliations

  • 1 Gastroenterology Department, Chenggong Hospital, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650505, Yunnan, China.
  • 2 Pain Department, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650055, Yunnan, China.
  • 3 Orthopedics Department, Chenggong Hospital, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650505, Yunnan, China.
  • 4 Obstetrics Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650000, Yunnan, China.
  • 5 Kunming Medical University, Kunming, 650500, Yunnan, China.
  • 6 Operating Room, Yunnan Pain Disease Hospital, Kunming, 650000, Yunnan, China.
  • 7 Orthopedics Department, Guang Nan Hospital of Traditional Chinese Medcine, Guangnan, 663300, Yunnan, China.
  • 8 Orthopedics Department, Hua Ning Country Hospital, Kunming, 652800, Yunnan, China.
  • 9 Orthopedics Department, Kunming City Resort District DaYu Street Community Health Service Center, Kunming, 650500, Yunnan, China.
  • 10 Orthopedics Department, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650055, Yunnan, China. yangxmkm@163.com.
  • # Contributed equally.
PMID: 40310592 DOI: 10.1007/s12033-025-01437-1
Abstract

Curcumin has strong anti-inflammatory properties and promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs). The aim of this study was to explore the role and potential molecular mechanism of curcumin in ameliorating osteogenic differentiation disorders caused by inflammation. We used LPS to induce an inflammatory response in hBMSCs. The expression of related mRNAs and proteins was detected by RT‒qPCR, Western blotting, immunofluorescence, and ELISA. The osteogenic differentiation of hBMSCs was detected by Alkaline Phosphatase (ALP) staining and alizarin red S (ARS) staining. The results showed that after LPS treatment, the levels of the inflammatory cytokines TNF-α, IL-6 and IL-1β in hBMSCs increased, and the activity of ALP, the level of calcium salt deposition and the expression levels of the osteogenic proteins RUNX2, COL1, OCN and OPN significantly decreased. The curcumin treatment alleviated this effect. These results indicated that curcumin improved the LPS-induced inflammation and osteogenic differentiation disorder in hBMSCs. Further studies revealed that the therapeutic effect of curcumin was caused by the inhibition of HMGB1 expression. From a mechanistic perspective, curcumin inhibits LPS-induced inflammation by inhibiting the expression of HMGB1, thereby inhibiting the NF-κB pathway and activating the NRF2 pathway, thereby improving the disordered osteogenic differentiation of hBMSCs. In conclusion, curcumin can reduce the LPS-induced inflammation of hBMSCs and ameliorate their osteogenic differentiation disorders.

Keywords

Bone marrow mesenchymal stem cells; Curcumin; HMGB1; NF-κB; NRF2; Osteogenic differentiation.

Figures
Products